4th quarter report and preliminary financials for 2020 for Medistim ASA

Sales for the quarter ended at MNOK 94.2 (MNOK 95.7), a decrease of 1.6%. Sales for 2020 ended at MNOK 363.1 (MNOK 363.7). Operating result (EBIT) for the quarter ended at MNOK 22.1 (MNOK 19.7) a 12.1% increase. Operating result the year 2020 ended at MNOK 95.5 (MNOK 89.8), a 6.4% increase. This is the best operating result for a year ever. Cashflow from operations was a solid MNOK 74.3. Cash by the end of the year was MNOK 71.9 after a dividend of MNOK 50.1 in November. Medistim has entered a Distribution agreement with LivaNova for India. The Board will suggest to the General Meeting a dividend of NOK 3.00 per share.